Quality name that has gone on sale. Q3 was very strong with improvising efficiencies. They are doing a buy back. Modeling 16% growth with a name trading at 14 times 2019 earnings. If the economy is fine, which it is their base case, this is a name you want to be buying now. (Analysts’ price target is $312.47)
They had a negative Q3 on their Pargazi contribution but their main business like Great-West Life and Investors Group were very solid. Very defensive name . Pays a very generous 6.7% dividend trading at 7 1/2 times earnings. Safe dividend and growth of 6%. If the market goes against you, something not to worry about. (Analysts’ price target is $33.29)